1992
HIV-1 infection and intravenous drug use: longitudinal neuropsychological evaluation of asymptomatic subjects.
Selnes O, McArthur J, Royal W, Updike M, Nance-Sproson T, Concha M, Gordon B, Solomon L, Vlahov D. HIV-1 infection and intravenous drug use: longitudinal neuropsychological evaluation of asymptomatic subjects. Neurology 1992, 42: 1924-30. PMID: 1407574, DOI: 10.1212/wnl.42.10.1924.Peer-Reviewed Original ResearchConceptsIntravenous drug usersIntravenous drug useDrug usersHIV infectionSerostatus groupsHIV-seropositive intravenous drug usersDrug useHIV-1 infectionHigh-risk groupRoute of acquisitionLongitudinal neuropsychological evaluationCross-sectional comparisonPreexisting deficitAsymptomatic subjectsLongitudinal followAdditional cognitive impairmentPresymptomatic stageNeurocognitive abnormalitiesCognitive impairmentNeuropsychological evaluationNeuropsychological deficitsSame cohortBisexual menInfectionSignificant differences
1991
Utilization of health services in a cohort of intravenous drug users with known HIV-1 serostatus.
Solomon L, Frank R, Vlahov D, Astemborski J. Utilization of health services in a cohort of intravenous drug users with known HIV-1 serostatus. American Journal Of Public Health 1991, 81: 1285-90. PMID: 1928527, PMCID: PMC1405342, DOI: 10.2105/ajph.81.10.1285.Peer-Reviewed Original ResearchConceptsIntravenous drug usersCD4 cell countDrug usersHealth servicesHIV serostatusClinical symptomsHIV-seropositive intravenous drug usersHealth insuranceCell countAsymptomatic HIV-1 infectionSeropositive intravenous drug usersHuman immunodeficiency virus (HIV) infectionHIV-seropositive drug usersOngoing natural history studyLow CD4 countHIV-1 seropositiveImmunodeficiency virus infectionHIV-1 serostatusHealth care utilizationHIV-1 infectionHIV-positive serostatusNatural history studiesHealth care servicesCD4 countMore HIV